GRK2 promoted TGFβ1-induced ECM accumulation by transcriptionally activating Smad3 in lung fibroblasts, the inhibition of which thus attenuated bleomycin-induced lung fibrosis [3]. The gene discussed is GRK2; the disease is pulmonary fibrosis.